Glenmark’s current portfolio consists of 173 products authorized for distribution in the U.S. marketplace and 46 ANDA’s pending approval with the U.S. FDA
According to IQVIA sales data for the 12-month period ending November 2021, the Ziac tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg market achieved annual sales of approximately US $ 30.3 million
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
New role strengthens Quantori’s global leadership position in data science & digital IT
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas
The company has 47 ANDA's pending approval with the U.S.FDA
Narayanan to lead SeQuent through next phase of consolidation and growth
The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival
Subscribe To Our Newsletter & Stay Updated
